Health News Society - Latest News Inbox

Home
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
About Us
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Business
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Health
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
lifestyle
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Fashion
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Technology
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Education
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article
Contact Us
New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical role of diagnostic equity in global public health and healthcare delivery. A new peer-reviewed study led by Mustafa A. Barbhuiya, PhD, Medical Director of Clinical Chemistry and Point-of-Care Testing at Baystate Medical Center and Assistant Professor of Pathology at UMass Chan Medical School–Baystate, examines a fundamental but often overlooked challenge in the global fight against tuberculosis (TB): whether patients have access to the essential diagnostic services needed to identify disease and drug resistance. He founded the Foundation for Advancement of Essential Diagnostics, a non-profit research and development organization in India to promote access to diagnostics and equity in healthcare delivery. The study, “Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India,” has been published in Microbiology Spectrum, a journal of the American Society for Microbiology. The research represents a significant academic contribution at the intersection of laboratory medicine, health systems, diagnostic equity, and global public health. Rather than focusing solely on the performance of an individual diagnostic test, the study examines diagnostic access as a component of healthcare delivery—asking whether essential TB diagnostic services are available at appropriate levels of the healthcare system. “Diagnosis is the gateway to effective treatment and disease control. In global health, we often focus on whether a technology exists. The more important healthcare-delivery question is whether that technology is accessible to the patient who needs it, at the right place and at the right time,” said Dr. Barbhuiya. From laboratory medicine to global health systems The study grew from Dr. Barbhuiya’s longstanding interest in the role of essential diagnostics in healthcare delivery and population health. At Baystate Medical Center, Springfield, Massachusetts, USA, Dr. Barbhuiya serves as Medical Director of Clinical Chemistry and Point-of-Care Testing and holds academic appointments in Pathology and Healthcare Delivery and Population Sciences at UMass Chan Medical School–Baystate. His academic work extends beyond the traditional boundaries of laboratory medicine to examine how diagnostic systems influence population health, particularly in resource-constrained settings. The current study represents an example of that approach: applying principles of laboratory medicine and healthcare delivery to a major global health challenge. The research combined a nationwide analysis of India's TB Treatment Units and Culture and Drug Susceptibility Testing (CDST) laboratories with a field assessment of 327 public healthcare facilities across seven states and Delhi. The study identified a 61.56% gap in CDST laboratory capacity based on the population-coverage requirements used in the analysis. At the primary-care level, only 4.94% of surveyed Primary Health Centers had the complete set of essential TB diagnostics recommended for that level of care. The researchers also documented variable availability of acid-fast bacilli microscopy, chest X-ray, molecular testing, and fluorescence microscopy across the surveyed facilities. Diagnostic equity as a healthcare-delivery issue The findings underscore an increasingly important principle in global health: the availability of healthcare technology does not necessarily translate into equitable healthcare delivery. A diagnostic test has limited population-health impact if patients cannot access it because of geographic, infrastructural, or health-system barriers. The study therefore moves the discussion of TB diagnosis beyond individual technologies and toward the broader architecture of healthcare delivery—including peripheral facilities, referral networks, laboratory capacity, and access to drug-resistance testing. “This is fundamentally a laboratory-equity issue, but it is also a healthcare-delivery issue. The laboratory is not isolated from the health system. Where diagnostic capacity is located, how patients reach it, whether testing can be performed reliably, and whether results can guide treatment all influence clinical outcomes and public health,” Dr. Barbhuiya added. A global health question with relevance beyond tuberculosis Although the research focuses on tuberculosis in India, the investigators believe the underlying question is applicable to many diseases and health systems. The World Health Organization's Essential Diagnostics List provides a framework for countries to identify diagnostic tests that should be available at different levels of their healthcare systems. The study examines how such a framework translates into actual diagnostic infrastructure on the ground. This has broader relevance for diseases ranging from infectious diseases to diabetes, cardiovascular disease, and cancer, where early and accurate diagnosis is essential for appropriate treatment and disease management. Dr. Barbhuiya founded the Foundation for Advancement of Essential Diagnostics (FAED) to advance the role of essential diagnostics in global health and healthcare delivery. His work has included research and policy engagement related to diagnostic access, laboratory systems, and essential diagnostics in India and other resource-constrained settings. A multidisciplinary and international collaboration The study brought together investigators from the Foundation for Advancement of Essential Diagnostics and collaborating institutions in India and the United States. The collaboration illustrates the increasingly international nature of academic medicine and health-services research, linking laboratory medicine expertise in the United States with field-based health systems research in India. The study also reflects the role that academic medical centers can play in addressing global health challenges through research that connects clinical expertise with population-level questions. Rigorous peer review strengthened the study The manuscript underwent multiple rounds of peer review before publication. Reviewers examined the study's sampling methodology, geographic representation, definition of diagnostic availability, private-sector coverage, human resources, diagnostic utilization, statistical methodology, and implications for laboratory equity. The authors subsequently revised the manuscript to clarify the study's scope and limitations, including distinguishing the multi-state facility assessment from the nationwide mapping of TB Treatment Units and CDST laboratories. The final manuscript was accepted for publication on June 27, 2026, and subsequently published in Microbiology Spectrum, an American Society of Microbiology journal. Building bridges between clinical medicine and global health The work illustrates how academic medicine can extend beyond the hospital and laboratory to address questions of population health and health-system performance. Dr. Barbhuiya's research agenda sits at the intersection of clinical laboratory medicine, diagnostics, healthcare delivery, and global health policy. “Our responsibility as academic physicians and scientists extends beyond diagnosing the individual patient in front of us. We also need to understand whether health systems are structured to make accurate diagnosis possible for entire populations, particularly populations that are underserved,” said Dr. Barbhuiya. The researchers are continuing work to characterize diagnostic infrastructure and access in India and to examine the broader role of essential diagnostics in strengthening healthcare delivery. Publication Barbhuiya MA, Chakraborty B, Laskar A, et al. Evaluating the nationwide availability of essential diagnostics for tuberculosis towards achieving a TB-free India. Microbiology Spectrum. 2026. DOI: 10.1128/spectrum.00703-26. Full article: Microbiology Spectrum – published article

Research group publishes landmark study examining diagnostic access in India’s fight against tuberculosis

New Delhi, August 14, 2026. A landmark study led by Dr. Mustafa Barbhuiya, Founder and Director, Foundation for Advancement of Essential Diagnostics, highlights the critical... Details

India’s TB elimination goal needs stronger diagnostic infrastructure at the point of care: peer-reviewed study

New Delhi [India], August 14: India's fight against tuberculosis needs to go beyond treatment and case notification and urgently focus on strengthening diagnostic infrastructure at... Details

Independence Day 2026: Urban Seniors Assert ‘Freedom after 65’

On India's 80th Independence Day, Samarth Life highlights how older adults are redefining independence, not by doing everything alone, but by having the right support... Details

Independence Day 2026: Urban Seniors Assert ‘Freedom after 65’

On India's 80th Independence Day, Samarth Life highlights how older adults are redefining independence, not by doing everything alone, but by having the right support... Details

Why is Glutone Revive Marine Collagen Tablet Becoming a Popular Choice for Skin Hydration and Elasticity?

There are many changes happening within the beauty and wellness market, where more consumers are moving away from topical solutions and embracing a more holistic... Details

The Diagnostic Clinical Simplifies Blood Test Booking

Kolkata, India: Life rarely slows down. Work. Family. Traffic. Endless to-do lists. Somewhere in between, people often ignore something important—their health. A blood test gets... Details

ICRAPAIN 2026 to Bring Global Pain Medicine Leaders to Kolkata

Kolkata (West Bengal) [India], July 8: Kolkata is set to host a major international academic gathering in Pain Medicine as ICRAPAIN 2026 -- International Conference on Recent... Details

When Rest Stops Working: What classical Ayurveda understands about professional exhaustion?

New Delhi [India], June 26: The alarm goes off. Eight hours have passed, give or take. You lie there for a moment, not reluctant exactly,... Details

Dant Kala, Dehradun: Transforming Dental Care with Trust, Comfort, and Advanced Dentistry

New Delhi [India], June 23: A healthy smile does way more than just look good on camera--it's a massive part of your overall wellness and... Details

Bastar’s Development Story Gains Global Spotlight as Dr. Mukesh Kumar Sets Guinness World Record in AI Healthcare

BHOPALPATNAM, BIJAPUR (CHHATTISGARH) — In a significant example of the rapid developmental change unfolding across Chhattisgarh, Dr. Mukesh Kumar, a frontline Medical Officer at the... Details

Latest post

OyeGifts Celebrates Every Sibling Bond with ‘Har Rishta, Ek Khaas Rakhi’ for Raksha Bandhan 2026

Research group publishes landmark study examining diagnostic access in India’s fight against tuberculosis

India’s TB elimination goal needs stronger diagnostic infrastructure at the point of care: peer-reviewed study

Popular Posts

Celebrate Diwali the earth-friendly way with Amala Earth (2039)

Dr. Tahera’s Heal360: Transforming Fertility Care Globally with Holistic, Natural Approach (1497)

From Search to Store: Vypzee Brings India’s Real Bazaars Online (1174)

How Sneha Oli’s vision crafted a Spa haven for her clients (1119)

UNARCHIVED – GROUP ART EXHIBITION BY MERAKII ART HOUSE, CURATED BY CHANDNI GULATI AGGARWAL (1070)

Stay Connected

Category: Health

Research group publishes landmark study examining diagnostic access in India’s fight against tuberculosis

India’s TB elimination goal needs stronger diagnostic infrastructure at the point of care: peer-reviewed study

Independence Day 2026: Urban Seniors Assert ‘Freedom after 65’

Independence Day 2026: Urban Seniors Assert ‘Freedom after 65’

Why is Glutone Revive Marine Collagen Tablet Becoming a Popular Choice for Skin Hydration and Elasticity?

The Diagnostic Clinical Simplifies Blood Test Booking

ICRAPAIN 2026 to Bring Global Pain Medicine Leaders to Kolkata

When Rest Stops Working: What classical Ayurveda understands about professional exhaustion?

Dant Kala, Dehradun: Transforming Dental Care with Trust, Comfort, and Advanced Dentistry

Bastar’s Development Story Gains Global Spotlight as Dr. Mukesh Kumar Sets Guinness World Record in AI Healthcare

Popular Post

Celebrate Diwali the earth-friendly way with Amala Earth (2039)

Dr. Tahera’s Heal360: Transforming Fertility Care Globally with Holistic, Natural Approach (1497)

From Search to Store: Vypzee Brings India’s Real Bazaars Online (1174)

How Sneha Oli’s vision crafted a Spa haven for her clients (1119)

UNARCHIVED – GROUP ART EXHIBITION BY MERAKII ART HOUSE, CURATED BY CHANDNI GULATI AGGARWAL (1070)